Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJing He, Zhanguo Li, Yaping Chen et al.|Nature Medicine|2016Cited by 570
[Exploration of the Predictive Value of Peripheral Blood-related Indicators for EGFR Mutations and Prognosis in Non-small Cell Lung Cancer Using Machine Learning].Shanlin Fu, Bo Shen, Shaodi Wen et al.|PubMed|2025Cited by 0